Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of DAB1 mRNA | increases expression | 20127859
|
D003024 |
Clozapine |
Clozapine results in increased expression of DAB1 mRNA | increases expression | 19359144
|
D005473 |
Fluoxetine |
Fluoxetine results in increased expression of DAB1 protein | increases expression | 19359144
|
D008628 |
Mercury |
Mercury results in increased expression of DAB1 mRNA | increases expression | 16823088
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of DAB1 mRNA | increases expression | 16780908
|
C076029 |
olanzapine |
olanzapine results in decreased expression of DAB1 protein | decreases expression | 19359144
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of DAB1 mRNA | decreases expression | 17426115
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of DAB1 mRNA | increases expression | 18301758
|
D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of DAB1 protein | decreases expression | 19359144
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of DAB1 mRNA | increases expression | 19359144
|
D002762 |
Cholecalciferol |
Cholecalciferol results in increased expression of DAB1 mRNA | increases expression | 17170073
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.77 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.13 | 19490988 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
9.89 | 11954676 16100012 19131640 12718980 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
9.89 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.02 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.76 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.76 | 16434500 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.31 | 14617031 12649775 16160616 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.55 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Fluoxetine |
9.88 | 18083778 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
9.88 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.33 | 19183758 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 15820235 |
MESH:D001321 |
Autistic Disorder |
|
Fluoxetine |
2.93 | 19232924 18775368 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.93 | 17497416 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
2.93 | 18685284 17069543 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.93 | 16609825 17507914 18396377 18316065 17157402 18985861 18177632 17688650 18940202 18558336 18775368 19460635 20603192 15238991 19232924 |
MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
12.11 | 16142846 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
12.11 | 16634805 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.17 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.35 | 19483382 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.52 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.01 | 20146248 17474063 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.10 | 20419170 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
3.51 | 10334427 |
MESH:D002389 |
Catatonia |
|
olanzapine |
6.57 | 16772815 18071103 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.77 | 20734317 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.97 | 19176532 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
5.22 | 17123785 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 8888407 16575769 |
MESH:D003866 |
Depressive Disorder |
|
Fluoxetine |
4.74 | 15014590 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
8.37 | 16823706 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
8.37 | 11298694 16780908 16823706 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.51 | 18249437 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.82 | 17069543 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
3.01 | 16402076 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.87 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.22 | 1733752 19641884 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.33 | 16402076 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.27 | 1851702 |
MESH:D004487 |
Edema |
|
Fluoxetine |
7.96 | 12798668 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.96 | 12083418 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.41 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.23 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.03 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.77 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.56 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.35 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.05 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.42 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.42 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.20 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.37 | 18558336 8888407 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.75 | 20471113 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.65 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.25 | 19176532 16221962 18467677 19772884 |
MESH:D019584 |
Hot Flashes |
|
Fluoxetine |
5.63 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.15 | 17688650 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.38 | 20558911 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
5.19 | 16046005 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
6.51 | 17933447 |
MESH:D007249 |
Inflammation |
|
Fluoxetine |
3.94 | 12798668 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.76 | 16306350 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
3.67 | 17934191 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.18 | 17596541 16294345 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
9.11 | 17567588 |
MESH:D008064 |
Lipidoses |
|
Fluoxetine |
9.11 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.59 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.59 | 20007298 15890375 16377806 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
4.88 | 20210726 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.58 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20464547 20064080 18816296 17053015 18569708 6695378 20869020 20135361 18520028 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
15.27 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Fluoxetine |
15.27 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
15.27 | 16856516 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
5.60 | 19142110 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.58 | 19142101 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.33 | 18765137 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.35 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.76 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.23 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.26 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.21 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.10 | 16411023 |
MESH:D009207 |
Myoclonus |
|
Fluoxetine |
6.16 | 8041377 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.13 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.13 | 17405874 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.25 | 16359493 8888407 |
MESH:D009765 |
Obesity |
|
Clozapine |
7.92 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
olanzapine |
7.92 | 18515891 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
7.92 | 20558911 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
Fluoxetine |
5.65 | 20418887 |
MESH:D010146 |
Pain |
|
Fluoxetine |
4.50 | 12798668 |
MESH:D020774 |
Pick Disease of the Brain |
|
Fluoxetine |
6.26 | 8041377 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.11 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.48 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
3.48 | 17024972 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.86 | 11422049 12752131 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
5.84 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
4.33 | 15331141 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.47 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.40 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
5.96 | 17726453 16141801 20521326 18855531 11763009 19369910 20580759 17667964 20452607 20168265 18806925 17123785 20107430 11151749 20521320 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
5.96 | 17726453 20521326 20107430 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
5.96 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.87 | 3137016 11738929 1511512 15475178 11044598 17978042 16876388 14763951 |
MESH:D020230 |
Serotonin Syndrome |
|
Fluoxetine |
6.21 | 8704074 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.45 | 19755658 10029692 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.94 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.86 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
5.57 | 20210726 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.55 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.81 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.24 | 17053015 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.90 | 8888407 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
10.97 | 17502770 16141801 20107430 16402076 20564506 20521320 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
10.97 | 17933447 20107430 19434072 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.36 | 17933447 |